Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026)
Zai Lab (ZLAB) posted Interest & Investment Income of $6.4 million for Q1 2026, down 11.12% sequentially from $7.3 million in Q4 2025, and down 25.09% YoY from $8.6 million in Q1 2025.
Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026) Analysis & Trends
Zai Lab has reported Interest & Investment Income for 7 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Interest & Investment Income fell 25.09% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.9 million (down 14.32% YoY) and the FY2025 annual result came in at $33.0 million, down 10.93% from the prior year.
- Interest & Investment Income retreated to $6.4 million in Q1 2026 per ZLAB's latest filing, from $7.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $10.3 million in Q4 2023 and troughed at $188000.0 in Q1 2022.
- A 5-year average of $7.7 million and a median of $9.0 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income surged 5342.55% in 2023, then dropped 25.09% in 2026.
- Over 5 years, Interest & Investment Income stood at $9.3 million in 2022, then rose by 10.24% to $10.3 million in 2023, then declined by 11.8% to $9.1 million in 2024, then slipped by 20.18% to $7.3 million in 2025, then declined by 11.12% to $6.4 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $6.4 million, $7.3 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 5.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88 Mn |
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.33 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 10.23 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 713,000.00 |